---
title: "Kronox Lab Sciences Ltd (KRONOX) — Share Price, Financials & Analysis"
symbol: "KRONOX"
company: "Kronox Lab Sciences Ltd"
canonical: "https://tapetide.com/stocks/KRONOX"
isin: "INE0ATZ01017"
nse_symbol: "KRONOX"
bse_code: "544187"
sector: "Chemicals"
industry: "Specialty Chemicals"
market_cap_cr: 631.92
generated_at: "2026-09-13T18:40:25.437Z"
---

# Kronox Lab Sciences Ltd (KRONOX)

Canonical page: https://tapetide.com/stocks/KRONOX

## Company

- **NSE Symbol:** KRONOX
- **BSE Code:** 544187
- **ISIN:** INE0ATZ01017
- **Sector:** Chemicals
- **Industry:** Specialty Chemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2024-06-10
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** kronoxlabsciences.com

## About

Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]

## Latest Price

- **Price:** ₹175.92
- **Change:** +3.96 (+2.3%)
- **Open:** ₹171.11
- **Day High:** ₹178.5
- **Day Low:** ₹170
- **Previous Close:** ₹171.96
- **Volume:** 71650
- **As Of:** 2026-09-11T10:24:22+00:00

## Key Fundamentals

Observed at 2026-09-11T04:52:48.538413Z.

- **Market Cap:** ₹631.92 Cr
- **Classification:** Microcap
- **P/E (reported):** 22.5
- **P/E (TTM):** 22.82
- **EPS (TTM):** ₹7.71
- **Book Value:** ₹31.3
- **Price to Book:** 5.52
- **Dividend Yield:** 0.29%
- **ROE:** 23.82%
- **ROCE:** 31.94%
- **Debt to Equity:** 0.02
- **Revenue (yearly):** ₹106.4 Cr
- **Net Income:** ₹27.7 Cr
- **EBITDA:** ₹39.5 Cr
- **52-Week High:** ₹223.42
- **52-Week Low:** ₹96
- **RSI (14):** 48.26

## Tapetide Score

- **Score:** 56 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 74.1 (of 4473 scored stocks)
- **Confidence:** 98%
- **Data coverage:** 95%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 86.12 | 9% |
| growth | 40.02 | 9% |
| momentum | 92.4 | 12% |
| ownership | 52.63 | 24% |
| quality | 84.39 | 22% |
| valuation | 34.84 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has delivered good profit growth of 23.2% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 31.4%
- Company's working capital requirements have reduced from 93.3 days to 71.2 days

### Weaknesses

- The company has delivered a poor sales growth of 10.1% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -22.18% | 37.14% | 164.86% |
| ebitda margin growth | -11.97% | 6.86% | 13.43% | 48.72% |
| net income growth | -8.75% | 8.63% | 19% | 23% |
| revenue growth | 4.95% | 3.6% | 2% | 10% |
| roce | — | -15.99% | -25.94% | 41.12% |
| roe | — | -15.71% | 28.09% | -29.46% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 21.02 | 20.71 | 22.18 | 25.19 | 24.86 | 24.01 | 26.13 | 24.29 | 25.53 | 25.27 | 26.13 | 28.39 |
| Expenses | 15.16 | 14.63 | 14.33 | 16.98 | 16.06 | 15.65 | 18.38 | 16.32 | 16.88 | 17.24 | 16.61 | 19.4 |
| Operating Profit | 5.86 | 6.08 | 7.85 | 8.21 | 8.8 | 8.36 | 7.75 | 7.97 | 8.65 | 8.03 | 9.52 | 8.99 |
| OPM % | 27.88 | 29.36 | 35.39 | 32.59 | 35.4 | 34.82 | 29.66 | 32.81 | 33.88 | 31.78 | 36.43 | 31.67 |
| Other Income | 0.49 | 0.02 | 0.83 | 0.43 | 0.36 | 0.82 | 0.91 | 0.87 | 1.04 | 1.13 | 2.15 | 1.3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.04 | 0.04 | 0.03 |
| Depreciation | 0.38 | 0.3 | 0.29 | 0.33 | 0.34 | 0.36 | 0.35 | 0.4 | 0.47 | 0.52 | 0.66 | 0.45 |
| Profit before tax | 5.97 | 5.8 | 8.39 | 8.31 | 8.82 | 8.82 | 8.31 | 8.44 | 9.18 | 8.6 | 10.97 | 9.81 |
| Tax % | 27.14 | 18.28 | 29.92 | 25.99 | 26.64 | 26.08 | 24.07 | 25.71 | 27.23 | 23.37 | 26.98 | 25.59 |
| Net Profit | 4.35 | 4.74 | 5.88 | 6.15 | 6.47 | 6.53 | 6.32 | 6.28 | 6.68 | 6.59 | 8 | 7.3 |
| EPS in Rs | 1.17 | 1.28 | 1.58 | 1.66 | 1.74 | 1.76 | 1.7 | 1.69 | 1.8 | 1.78 | 2.16 | 1.97 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 50 | 62 | 82 | 96 | 90 | 100 | 101 | 105 |
| Expenses | 39 | 48 | 63 | 74 | 62 | 67 | 67 | 70 |
| Operating Profit | 12 | 15 | 20 | 22 | 28 | 33 | 34 | 35 |
| OPM % | 23 | 24 | 24 | 23 | 32 | 33 | 34 | 33 |
| Other Income | 1 | 1 | 1 | 2 | 2 | 3 | 5 | 6 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
| Profit before tax | 12 | 13 | 18 | 22 | 29 | 34 | 37 | 39 |
| Tax % | 27 | 26 | 26 | 26 | 25 | 26 | 26 | — |
| Net Profit | 9 | 10 | 14 | 16 | 21 | 25 | 28 | 29 |
| EPS in Rs | 343.6 | 403.73 | 565.56 | 4.42 | 5.75 | 6.86 | 7.45 | 7.71 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 9 | 7 | 7 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.25 | 0.24 | 0.24 | 37 | 37 | 37 | 37 |
| Reserves | 23 | 27 | 40 | 8 | 29 | 53 | 79 |
| Borrowings | 0 | 4 | 3 | 0 | 0 | 0 | 2 |
| Other Liabilities | 11 | 7 | 13 | 9 | 8 | 9 | 10 |
| Total Liabilities | 34 | 38 | 57 | 54 | 74 | 99 | 128 |
| Fixed Assets | 6 | 9 | 11 | 16 | 26 | 28 | 29 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 29 | 28 | 45 | 38 | 47 | 70 | 98 |
| Total Assets | 34 | 38 | 57 | 54 | 74 | 99 | 128 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4 | 11 | 9 | 20 | 17 | 31 | 24 |
| Cash from Investing Activity | -4 | -3 | -8 | -7 | -17 | -28 | -24 |
| Cash from Financing Activity | 0 | -7 | -1 | -13 | 0 | -2 | 0 |
| Net Cash Flow | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 3 | 10 | 5 | 11 | 5 | 28 | 21 |
| CFO/OP | 65 | 100 | 70 | 117 | 87 | 120 | 98 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 110 | 90 | 114 | 71 | 72 | 72 | 76 |
| Inventory Days | 70 | 58 | 58 | 61 | 74 | 47 | 66 |
| Days Payable | 102 | 69 | 89 | 52 | 51 | 54 | 52 |
| Cash Conversion Cycle | 78 | 79 | 84 | 80 | 94 | 66 | 90 |
| Working Capital Days | 100 | 95 | 122 | 83 | 143 | 65 | 71 |
| ROCE % | — | 50 | 51 | 50 | 52 | 44 | 36 |

## Shareholding Pattern

### Quarterly

| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% |
| FIIs | 1.56% | 0.55% | 0.48% | 0.04% | 0.03% | 0.03% | 0.05% | 0.08% | 0.04% |
| DIIs | 5.43% | 2.57% | 2.2% | 2.2% | 1.71% | 1.93% | 2% | 2.05% | 2.07% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 16.26% | 20.58% | 20.2% | 20.54% | 21.41% | 21.2% | 21.13% | 20.98% | 20.82% |
| Others | 2.54% | 2.09% | 2.9% | 3.01% | 2.64% | 2.63% | 2.62% | 2.68% | 2.85% |
| No. of Shareholders | 31450 | 39792 | 38489 | 37922 | 37569 | 35780 | 34608 | 33469 | 32479 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 9 / 4 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 179.18 | Sell |
| EMA (10) | 177.92 | Sell |
| SMA (20) | 180.32 | Sell |
| EMA (20) | 176.92 | Sell |
| SMA (50) | 165.2 | Buy |
| EMA (50) | 167.62 | Buy |
| SMA (100) | 152.48 | Buy |
| EMA (100) | 156.99 | Buy |
| SMA (200) | 140.02 | Buy |
| EMA (200) | 150.25 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.71 | Neutral |
| MACD (12,26,9) | 3 | Sell |
| Stochastic (14,3,3) | 16.03 | Buy |
| ADX (14) | 25.92 | Buy |
| Williams %R (14) | -74.82 | Neutral |
| ATR (14) | 11.16 | High Volatility |
| ROC (12) | -9.99 | Sell |
| Stoch RSI (14) | 17.73 | Buy |
| UO (7,14,28) | 38.71 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-05 | [Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - Receipt Of Draft Letter Of Offer (DLOF) For Open Offer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=965c53a2-92a6-4883-85c6-c76765edc28d.pdf) |
| 2026-09-04 | [Draft Letter of Offer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E5F46466-6EBC-423C-B0C6-484775A8275D-172059.pdf) |
| 2026-08-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f2f7d552-2930-4277-b69c-c13cfc7c7775.pdf) |
| 2026-08-28 | [Detailed Public Statement - Updates on Open Offer](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71D856CE-547D-40F5-BA64-3437A3034E6B-191249.pdf) |
| 2026-08-28 | [Publication Of Detailed Public Statement (DPS) In Connection With The Open Offer To The Shareholders Of KRONOX LAB SCIENCES LIMITED](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edb17852-4b9a-4377-8d93-22df7cc5b17b.pdf) |
| 2026-08-24 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f872b7a-c4ab-41c7-9262-12bffaed229c.pdf) |
| 2026-08-24 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3353f999-015c-48ee-bab7-d9aa3d6f23ff.pdf) |
| 2026-08-24 | [Notice Of 17Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4aec4f89-f217-47f0-a63d-6f178e33b4dd.pdf) |
| 2026-08-24 | [Record Date For The Purpose Of Final Dividend](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=634a4043-b5d4-4075-8c52-dc5eee3f7dad.pdf) |
| 2026-08-21 | [Announcement under Regulation 30 (LODR)-Acquisition](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01fa39ae-63a9-4d0f-8260-e07dc9714f32.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Standalone Unaudited Financail Results For The Quarter Ended June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03380acb-e15e-46b3-9b74-8ccb58720e10.pdf) |
| 2026-05-21 | [Audited Standalone Financial Results For The Quarter And Year Ended On March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4c8de5ae-4d85-4704-bc7d-91f145c970a2.pdf) |
| 2026-02-14 | [Un Audited Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=92e65f8e-dd92-4f7b-8589-cf9d25207806.pdf) |
| 2025-11-11 | [Unaudited Financial Results For The Quarter And Half Year Ended September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e128bb3d-50f5-435b-b6b9-a3199514f9ae.pdf) |
| 2025-08-11 | [Un-Audited Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46dc160c-56e0-4b2e-baeb-4ecb5caa65fc.pdf) |
| 2025-05-22 | [Results- Financial Results For The Quarter And Year Ended On March 312025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=984f1cb2-7a03-4d5a-8eeb-85190cf56e13.pdf) |
| 2025-01-31 | [Financial Results For The Quarter And Nine-Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a9bf436-2051-4305-b88e-9ff0a05f78f9.pdf) |
| 2024-11-12 | [Financial Results For The Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41a2ca2e-f954-49a3-bdc4-39d8a78fdcee.pdf) |
| 2024-08-06 | [Results-Financial Results For The Quarter Ended 30Th June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=358b3b22-26fb-4c81-8a74-872b7c019cca.pdf) |
| 2024-06-28 | [Results- Financail Results For The Quarter And Year Ended 31St March, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=892d8dfc-55e2-4475-bd22-8958923a94ff.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Board meeting Feb 14, 2026 to approve Q3 and nine-month results (Dec 31, 2025); trading window closed. | [Board Meeting Intimation for Consideration Of Un-Audited Financial Results For The Quarter And Nine Months Ended December 31, 2025 9 Feb - Board meeting Feb 14, 2026 to approve Q3 and nine-month results (Dec 31, 2025); trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a320de53-905a-44b7-86a8-c9f3e060182f.pdf) |
| 8 Apr - Kronox Lab Sciences clarifies share price movement is market-driven and no undisclosed information exists. | [Clarification On Price Movement 8 Apr - Kronox Lab Sciences clarifies share price movement is market-driven and no undisclosed information exists.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac449bb2-8c44-4f00-b8a6-a1aa4c5c0209.pdf) |
| 3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73598a87-2c9f-4272-b0ec-86c37bd7a178.pdf) |
| 16 Feb - Newspaper Publication for Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb - Newspaper Publication for Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/168198a8-ff38-44d0-be57-63747d9ca1df.pdf) |
| 14 Feb - Unaudited Q3/9M results (31-Dec-2025): Q3 revenue Rs2,527.40L; Q3 PAT Rs658.90L; 9M PAT Rs1,965.79L. | [Board Meeting Outcome for Outcome Of Board Meeting Held On February 14, 2026 14 Feb - Unaudited Q3/9M results (31-Dec-2025): Q3 revenue Rs2,527.40L; Q3 PAT Rs658.90L; 9M PAT Rs1,965.79L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9b426b95-519c-4afa-9490-d20a430a2239.pdf) |
| 14 Feb - Unaudited Q3/9M (31 Dec 2025): Qtr revenue Rs2,527.40L; 9M revenue Rs7,509.37L; 9M PAT Rs1,965.79L | [Un Audited Financial Results For The Quarter And Nine Months Ended December 31, 2025 14 Feb - Unaudited Q3/9M (31 Dec 2025): Qtr revenue Rs2,527.40L; 9M revenue Rs7,509.37L; 9M PAT Rs1,965.79L](https://www.bseindia.com/xml-data/corpfiling/AttachHis/92e65f8e-dd92-4f7b-8589-cf9d25207806.pdf) |
| — | [Closure of Trading Window 26 Mar](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7fb1992c-59a4-4138-b596-a5dcb4f0d1e7.pdf) |
| — | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Jan](https://www.bseindia.com/xml-data/corpfiling/AttachHis/025a7594-cec6-4f42-bc93-422b55557955.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5daa8fca-3154-4939-b322-5a9ebb230fd7.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8cda34fd-e700-4fbb-ae5d-c215cb7a976a.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:40:25.437Z.